×
About 403 results

ALLMedicine™ Pituitary Hormone Deficiency Center

Research & Reviews  153 results

Approach to a case with an unusual cause of hypopituitarism.
https://doi.org/10.1210/clinem/dgac747
The Journal of Clinical Endocrinology and Metabolism; Das L, Dutta P

Dec 28th, 2022 - Hypopituitarism refers to insufficiency of one or more hormones of the pituitary and can be due to myriad causes. The clinical and radiological spectrum of the condition is heterogeneous, based on the age, gender, clinical setting and/or other pas...

POU1F1/Pou1f1 c.143-83A > G Variant Disrupts the Branch Site in Pre-mRNA and Leads to D...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795478
Endocrinology Akiba K, Hasegawa Y et. al.

Nov 26th, 2022 - POU Class 1 Homeobox1 (POU1F1/Pou1f1) is a well-established pituitary-specific transcription factor, and causes, when mutated, combined pituitary hormone deficiency in humans and mice. POU1F1/Pou1f1 has 2 isoforms: the alpha and beta isoforms. Rec...

Normal or elevated prolactin is a good indicator to show pituitary stalk interruption s...
https://doi.org/10.1515/jpem-2022-0366
Journal of Pediatric Endocrinology & Metabolism : JPEM; Eren E, Ongen YD et. al.

Sep 23rd, 2022 - To determine the importance of serum prolactin (PRL) in the detection of pituitary stalk interruption syndrome (PSIS) in children with multiple pituitary hormone deficiency (MPHD). We hypothesized that PRL elevation might be a diagnostic indicator...

Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma.
https://doi.org/10.1007/s11102-022-01259-3
Pituitary Rudman Y, Duskin-Bitan H et. al.

Aug 30th, 2022 - To study the baseline characteristics predicting hypogonadotropic hypogonadism (HH) persistence in men with macroprolactinoma that achieved prolactin normalization. Retrospective cohort study. Male patients diagnosed with macroprolactinoma and HH ...

Heterozygous variants in SIX3 and POU1F1 cause pituitary hormone deficiency in mouse an...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851746
Human Molecular Genetics; Bando H, Brinkmeier ML et. al.

Aug 12th, 2022 - Congenital hypopituitarism is a genetically heterogeneous condition that is part of a spectrum disorder that can include holoprosencephaly. Heterozygous mutations in SIX3 cause variable holoprosencephaly in humans and mice. We identified two child...

see more →

Clinicaltrials.gov  5 results

Incidence of cCPHD in Denmark - a National Observational Study
https://clinicaltrials.gov/ct2/show/NCT05334563

Jul 7th, 2022 - Background Congenital combined pituitary hormone deficiency (cCPHD) is defined as the partial or complete loss of more than one hormone secreted from the pituitary gland, caused by genetic or prenatal factors. Combined pituitary hormone deficiency...

Quality of Life and Psychosocial Dimension in Children With Hypopituitarism
https://clinicaltrials.gov/ct2/show/NCT05403255

Jun 3rd, 2022 - Objectives: Describe the quality of life and psychosocial repercussions of the disease in children 10-17 years of age with multiple pituitary hormone deficiency (either acquired or congenital), or isolated pituitary hormone deficiency (other than ...

Anterior Pituitary Hormone Replacement in Traumatic Brain Injury
https://clinicaltrials.gov/ct2/show/NCT00957671

Jun 29th, 2018 - This protocol is designed to screen and detect evidence of pituitary hormone deficiency in adults following traumatic brain injury. Growth hormone deficiency will be replaced for a period of one year. Subject will not be screened until at least on...

Testosterone and Growth Hormone for Bone Loss in Men
https://clinicaltrials.gov/ct2/show/NCT00080483

Jun 13th, 2014 - Replacement of testosterone or growth hormone in patients who are deficient improves osteoporosis associated with these deficiencies. In some tissues, such as muscle, the effects of testosterone and growth hormone are additive, but it is not known...

Hormone Deficiency After Brain Injury During Combat
https://clinicaltrials.gov/ct2/show/NCT01666964

Aug 16th, 2012 - The prevalence of hypopituitarism after combat-related traumatic brain injury (TBI) is currently unknown. Recent civilian data on TBI show the prevalence of any pituitary hormone deficiency is as high as 80% after 12 months. While the military pre...

see more →

News  1 results

Immune Checkpoint Inhibitor-Related Hypophysitis and Endocrine Dysfunction
https://www.medscape.com/viewarticle/869276

Abstract and Introduction Abstract Immune checkpoint inhibitors are a new and effective class of cancer therapy, with ipilimumab being the most established drug in this category. The drugs' mechanism of action includes promoting the effector T cel...

see more →

Patient Education  2 results see all →